The effects of etidronate disodium on progressive hearing loss from otosclerosis

D. W. Kennedy, Michael E Hoffer, M. Holliday

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

A 2-year prospective double-blind study was performed to evaluate the role of etidronate disodium for the treatment of progressive hearing loss in patients with otosclerosis. A pulsed dosage regimen was used during the 2- year period and the patients were followed up with otologic and audiometric examinations. Although statistically significant differences were not achieved between the study and control groups, the study did reveal a trend toward stabilization or improvement in air conduction thresholds in some frequencies (1000 and 4000 Hz) and in bone conduction thresholds at other frequencies (500, 1000, and 2000 Hz). The incidence of adverse side effects was similar in the treatment and control groups. Although no definite conclusions can be drawn from this pilot study, the findings provide encouragement for performing a larger and longer-term study.

Original languageEnglish (US)
Pages (from-to)461-467
Number of pages7
JournalOtolaryngology - Head and Neck Surgery
Volume109
Issue number3 I
StatePublished - 1993
Externally publishedYes

Fingerprint

Etidronic Acid
Otosclerosis
Hearing Loss
Bone Conduction
Control Groups
Double-Blind Method
Air
Incidence
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

The effects of etidronate disodium on progressive hearing loss from otosclerosis. / Kennedy, D. W.; Hoffer, Michael E; Holliday, M.

In: Otolaryngology - Head and Neck Surgery, Vol. 109, No. 3 I, 1993, p. 461-467.

Research output: Contribution to journalArticle

@article{a8c15ea086b442948cb305552bdd6838,
title = "The effects of etidronate disodium on progressive hearing loss from otosclerosis",
abstract = "A 2-year prospective double-blind study was performed to evaluate the role of etidronate disodium for the treatment of progressive hearing loss in patients with otosclerosis. A pulsed dosage regimen was used during the 2- year period and the patients were followed up with otologic and audiometric examinations. Although statistically significant differences were not achieved between the study and control groups, the study did reveal a trend toward stabilization or improvement in air conduction thresholds in some frequencies (1000 and 4000 Hz) and in bone conduction thresholds at other frequencies (500, 1000, and 2000 Hz). The incidence of adverse side effects was similar in the treatment and control groups. Although no definite conclusions can be drawn from this pilot study, the findings provide encouragement for performing a larger and longer-term study.",
author = "Kennedy, {D. W.} and Hoffer, {Michael E} and M. Holliday",
year = "1993",
language = "English (US)",
volume = "109",
pages = "461--467",
journal = "Otolaryngology - Head and Neck Surgery (United States)",
issn = "0194-5998",
publisher = "Mosby Inc.",
number = "3 I",

}

TY - JOUR

T1 - The effects of etidronate disodium on progressive hearing loss from otosclerosis

AU - Kennedy, D. W.

AU - Hoffer, Michael E

AU - Holliday, M.

PY - 1993

Y1 - 1993

N2 - A 2-year prospective double-blind study was performed to evaluate the role of etidronate disodium for the treatment of progressive hearing loss in patients with otosclerosis. A pulsed dosage regimen was used during the 2- year period and the patients were followed up with otologic and audiometric examinations. Although statistically significant differences were not achieved between the study and control groups, the study did reveal a trend toward stabilization or improvement in air conduction thresholds in some frequencies (1000 and 4000 Hz) and in bone conduction thresholds at other frequencies (500, 1000, and 2000 Hz). The incidence of adverse side effects was similar in the treatment and control groups. Although no definite conclusions can be drawn from this pilot study, the findings provide encouragement for performing a larger and longer-term study.

AB - A 2-year prospective double-blind study was performed to evaluate the role of etidronate disodium for the treatment of progressive hearing loss in patients with otosclerosis. A pulsed dosage regimen was used during the 2- year period and the patients were followed up with otologic and audiometric examinations. Although statistically significant differences were not achieved between the study and control groups, the study did reveal a trend toward stabilization or improvement in air conduction thresholds in some frequencies (1000 and 4000 Hz) and in bone conduction thresholds at other frequencies (500, 1000, and 2000 Hz). The incidence of adverse side effects was similar in the treatment and control groups. Although no definite conclusions can be drawn from this pilot study, the findings provide encouragement for performing a larger and longer-term study.

UR - http://www.scopus.com/inward/record.url?scp=0027425713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027425713&partnerID=8YFLogxK

M3 - Article

C2 - 8414563

AN - SCOPUS:0027425713

VL - 109

SP - 461

EP - 467

JO - Otolaryngology - Head and Neck Surgery (United States)

JF - Otolaryngology - Head and Neck Surgery (United States)

SN - 0194-5998

IS - 3 I

ER -